Inactive Instrument

Press Releases CTI BioPharma Corp.

Equities

CTIC

US12648L6011

Press Releases

Unlock all the news on all businesses: Never miss an investment opportunity again!

Sobi publishes Q3 2023 report: Strong revenue and solid performance	23-10-30	AQ
Sobi completes acquisition of CTI BioPharma Corp.	23-06-27	AQ
Sobi successfully completes tender offer for all outstanding shares of common stock of CTI BioPharma Corp.	23-06-24	PR
Sobi successfully completes tender offer for all outstanding shares of common stock of CTI BioPharma Corp.	23-06-24	AQ
CTI BIOPHARMA INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of CTI BioPharma Corp. - CTIC	23-06-06	BU
CTI BioPharma Announces Cancellation of its 2023 Annual Meeting of Stockholders	23-05-30	PR
Sobi commences tender offer for all outstanding shares of common stock of CTI BioPharma Corp.	23-05-25	AQ
CTI BioPharma: Q1 Earnings Snapshot	23-05-16	AQ
$1.7b acquisition to develop rare haematology therapy	23-05-12	AQ
CTI BIOPHARMA INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of CTI BioPharma Corp. - CTIC	23-05-10	BU
Shareholder Alert: Ademi LLP investigates whether CTI BioPharma Corp. has obtained a Fair Price in its transaction with Sobi	23-05-10	PR
CTIC STOCK ALERT: Halper Sadeh LLC Is Investigating Whether the Sale of CTI BioPharma Corp. Is Fair to Shareholders	23-05-10	BU
CTI BioPharma : TENDER AND SUPPORT AGREEMENT - Form 8-K	23-05-10	PU
CTI BIOPHARMA CORP : Entry into a Material Definitive Agreement, Amendments to Articles of Inc. or Bylaws; Change in Fiscal Year, Other Events, Financial Statements and Exhibits (form 8-K)	23-05-10	AQ
Sobi to Acquire CTI BioPharma	23-05-10	PR
Investor supports Sobi's tender offer for CTI BioPharma and undertakes to subscribe for its pro rata share in Sobi's rights issue	23-05-10	AQ
Sobi to acquire CTI BioPharma Corp. enhancing Sobi's position in rare haematology	23-05-10	AQ
CTI BioPharma Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)	23-05-04	PR
CTI BioPharma Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)	23-05-02	PR
CTI BioPharma To Report First Quarter 2023 Financial Results and Provide Corporate Update on Thursday, May 11, 2023	23-05-01	PR

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Press Releases CTI BioPharma Corp.

Equities

CTIC

US12648L6011

Press Releases

Filters